US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

Sennosides

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.

What was recalled

SENNOSIDES, Tablet, 8.6 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00182109301.

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-876-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sennosides recalls

See all
Class I · High risk Terminated

SENNA Syrup

Reason Microbial Contamination of Non-Sterile Product

Lohxa, LLC NDC 50262-731-24 D-0377-2022
Class III · Low risk Terminated

Sankaijo BOTANICAL LAXATIVE

Reason Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.

Sato Pharmaceutical Inc. NDC 49873-404-01 D-0303-2020
Class II · Moderate risk Terminated

Senna

Reason Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Geritrex, LLC NDC 54162-007-08 D-1437-2019
Class II · Moderate risk Terminated

Senna

Reason Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Geritrex, LLC NDC 53807-556-08 D-1436-2019
Class II · Moderate risk Terminated

SDA Senna Syrup

Reason CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

RIJ Pharmaceutical LLC NDC 66424-562-08 D-0851-2018